SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-022813
Filing Date
2022-06-09
Accepted
2022-06-09 08:15:17
Documents
14
Period of Report
2022-06-09
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apvo-8k_20220609.htm   iXBRL 8-K 35528
2 EX-99.1 apvo-ex991_15.htm EX-99.1 42636
3 GRAPHIC gv5e30zb0f2i000001.jpg GRAPHIC 2804
  Complete submission text file 0001564590-22-022813.txt   218408

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA apvo-20220609.xsd EX-101.SCH 5733
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20220609_lab.xml EX-101.LAB 19431
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20220609_pre.xml EX-101.PRE 11612
8 EXTRACTED XBRL INSTANCE DOCUMENT apvo-8k_20220609_htm.xml XML 3539
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37746 | Film No.: 221004969
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences